Adaptive power priors with empirical Bayes for clinical trials by Gravestock, Isaac & Held, Leonhard
Zurich Open Repository and
Archive
University of Zurich
Main Library
Strickhofstrasse 39
CH-8057 Zurich
www.zora.uzh.ch
Year: 2017
Adaptive power priors with empirical Bayes for clinical trials
Gravestock, Isaac; Held, Leonhard
Abstract: Incorporating historical information into the design and analysis of a new clinical trial has been
the subject of much discussion as a way to increase the feasibility of trials in situations where patients
are difficult to recruit. The best method to include this data is not yet clear, especially in the case when
few historical studies are available. This paper looks at the power prior technique afresh in a binomial
setting and examines some previously unexamined properties, such as Box P values, bias, and coverage.
Additionally, it proposes an empirical Bayes-type approach to estimating the prior weight parameter by
marginal likelihood. This estimate has advantages over previously criticised methods in that it varies
commensurably with differences in the historical and current data and can choose weights near 1 when
the data are similar enough. Fully Bayesian approaches are also considered. An analysis of the operating
characteristics shows that the adaptive methods work well and that the various approaches have different
strengths and weaknesses.
DOI: https://doi.org/10.1002/pst.1814
Posted at the Zurich Open Repository and Archive, University of Zurich
ZORA URL: https://doi.org/10.5167/uzh-146025
Journal Article
Accepted Version
Originally published at:
Gravestock, Isaac; Held, Leonhard (2017). Adaptive power priors with empirical Bayes for clinical trials.
Pharmaceutical Statistics, 16(5):349-360.
DOI: https://doi.org/10.1002/pst.1814
Research Article
Received XXXX
(www.interscience.wiley.com) DOI: 10.1002/sim.0000
Adaptive power priors with empirical Bayes for
clinical trials
Isaac Gravestock 1*, Leonhard Held 1
Incorporating historical information into the design and analysis of a new clinical trial has been the
subject of much discussion as a way to increase the feasibility of trials in situations where patients
are difficult to recruit. The best method to include this data is not yet clear, especially in the case
when few historical studies are available. This paper looks at the power prior technique afresh in a
binomial setting and examines some previously unexamined properties, such as Box p-values, bias
and coverage. Additionally it proposes an empirical Bayes type approach to estimating the prior
weight parameter by marginal likelihood. This estimate has advantages over previously criticised
methods in that it varies commensurably with differences in the historical and current data and
can choose weights near 1 when the data are similar enough. Fully Bayesian approaches are also
considered. An analysis of the operating characteristics shows that the adaptive methods work well
and that the various approaches have different strengths and weaknesses. Copyright © 0000 John
Wiley & Sons, Ltd.
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1. Introduction
The incorporation of historical data into clinical trials has become an important topic, as statisticians, sponsors and
regulators seek the best ways to continue development in difficult disease areas. Viele et al. [28] have written an excellent
overview of the approaches and associated issues. One of the methods considered in that paper is the conditional power
prior (with fixed prior weight). This paper is intended to complement that review by looking more closely at the power
prior and methods allowing it to be used adaptively which are not discussed by Viele et al.
The power prior is described in a series of articles (Chen, Ibrahim, and Shao [7], Ibrahim and Chen [18], Ibrahim,
Chen, and Sinha [20], Chen and Ibrahim [6]; Ibrahim et al. [19]), showing it is a flexible technique and can be applied
to a wide range of models, including GLMs and Cox models. Central to the power prior is a weight parameter which
determines how much information is used from the historical data. The original formulation is conditional on the weight
parameter, but a modification which includes an important normalising factor allows the weight to be treated as unknown
[10, 11, 22]. Several authors have criticised the use of unknown weights in power priors [15, 21], claiming they do not
adapt appropriately to the difference or similarity between historical and current data. However, we show in this paper that
they do behave well given a suitable estimation procedure.
To this end, we propose an empirical Bayes (EB) approach to power prior construction. The main idea of EB is
to estimate prior parameters empirically, i. e., from the observed data. It can be considered as hybrid of Bayesian and
frequentist thinking and is described clearly in [4]. For power priors, we will use EB methodology to estimate the weight
parameter based on the historical and current data. Hobbs et al. [17] present EB estimates for a closely related prior for
normal distributions and show their application in generalised linear modelling. Another related approach using EB for
adaptive prior weighting is proposed by Held and Sauter [14]. These data-based estimation methods lend themselves to
an adaptive trial design, where sample size [13] or randomisation could be adjusted based on the updated prior [16]. For
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comparison, we also examine a fully Bayesian approach to power prior construction. A non-Bayesian alternative is the
test-then-pool methodology [28], which compares the historical and current data and, if their difference is not significant
at a prespecified level, then the historical and current data are combined in the analysis.
In the context of clinical trials of antibiotics for drug resistant infections, where patients with specific infections can be
difficult to recruit, there is often little relevant historical clinical trial information available, which means that we require
methods that can appropriately make the best use of whatever information is available. However, we must be careful
to acknowledge the evolving resistance and different contexts of historical clinical trials, which means the methodology
must handle prior-data conflict appropriately. The FDA draft guidelines for antibacterial therapies for patients with unmet
needs [5] discusses the possibility of using results from historical trials and how external data could be incorporated in a
down-weighted fashion. We consider power prior methodology to be suitable for this purpose.
1.1. Notation
We construct our informative prior based on the data, x0, from a single historical study. The data coming from the current
study is denoted x?. The central assumption of the power prior is that the parameter underlying the historical data, θ0,
is similar enough to that underlying the current data, θ, that x0 can be informative about θ. Therefore the priors and
posteriors are constructed with likelihoods L(θ;x0) and L(θ;x?), both around θ. Since this assumption may not be fully
met, we control the influence of the historical study on the prior with a weight parameter δ which has a value between 0
and 1.
In clinical trials we are often interested in a binary outcome such as cured/not cured or mortality. In this setting, x0 and
x? represent the number patients who have an event, while the total number of patients in the historical and current trials
are fixed and denoted by n0 and n?. The parameter of interest is the success proportion, pi, so we use binomial likelihoods,
L(pi;x0) and L(pi;x?). Since we are developing priors based on previous trials, patient-level data may not be available,
therefore we only make use of summary-level data. This paper will focus on the cases where the data can be modelled
with binomial distributions, but the methodology can be applied more generally. Derivations for normal distributions are
given in Appendix A.
2. The Power Prior
If a previous clinical trial has been conducted using the same treatment as that to be used in a new trial, then information
from that previous trial may be informative and can be incorporated into the design or analysis of the new trial. The power
prior is an especially suitable method of incorporating historical data when only a single previous study available as it
does not require the estimation of the heterogeneity between studies [3], unlike a hierarchical model or meta-analysis
prior [24, 27].
2.1. Fixed Power Parameter
In its simplest form the power prior is proportional to the likelihood of the historical data raised to the power of the weight
δ ∈ [0, 1] multiplied by the initial prior p(θ), i. e.
p(θ |x0, δ) ∝ L(θ;x0)δ p(θ). (1)
It is therefore a posterior based on the historical data with a modified likelihood. The weighting is a very neat construction
because when δ = 0, the likelihood component is 1, and thus the power prior is equal to the initial prior and at the other
extreme, when δ = 1, the historical data is used fully, which corresponds to the usual Bayesian updating of the initial prior.
This is the original power prior and because it is conditional on the weight parameter δ, it requires that it is known and
fixed. The modified power prior which allows the weight to vary is discussed in Section 2.2.
In the binomial setting with unknown proportion pi and sample size n0, the power prior is
p(pi |x0, δ) ∝
(
n0
x0
)δ
piδx0(1− pi)δ(n0−x0) p(pi).
The posterior, based on x? and n?, is
p(pi |x?, x0, δ) ∝
(
n0
x0
)δ(
n?
x?
)
piδx0+x?(1− pi)δ(n0−x0)+(n?−x?) p(pi). (2)
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2.2. Full Bayes
Instead of conditioning on the fixed weight, δ can be treated as an unknown parameter and a prior distribution for it can be
included in the formulation. The varying power affects the likelihood such that the constants can no longer be ignored [9];
this requires a normalising constant to be calculated by integrating the original power prior expression over the parameter
θ. The joint power prior is then
p(θ, δ |x0) = p(θ | δ, x0) p(δ), (3)
where
p(θ | δ, x0) = L(θ;x0)
δ p(θ)∫
L(θ;x0)δ p(θ)dθ
. (4)
As the weight parameter is limited to 0 ≤ δ ≤ 1, a commonly suggested prior is that δ ∼ Be(α, β). By integrating out the
weight parameter, we can find the marginal distribution of θ for fully Bayesian inference [10, 11]. Based on (3), the joint
power prior for the event probability pi and δ [10] is
p(pi, δ |x0) = pi
δx0+αpi−1(1− pi)δ(n0−x0)+βpi−1
B(δx0 + αpi, δ(n0 − x0) + βpi) Be(δ |α, β), (5)
where B(·, ·) denotes the beta function and we use a beta prior for the effect parameter, pi ∼ Be(αpi, βpi). Multiplying (5)
by the likelihood of the current data L(x?;pi) gives the joint posterior,
p(pi, δ |x0, x?) ∝ pi
δx0+x?+αpi−1(1− pi)δ(n0−x0)+(n?−x?)+βpi−1
B(δx0 + αpi, δ(n0 − x0) + βpi) Be(δ |α, β). (6)
The marginal posterior distribution of pi is
p(pi |x0, x?) ∝
∫ 1
0
p(pi, δ |x0, x?)dδ.
There is no closed form expression due to the beta function in (6), however it can be easily evaluated numerically for full
Bayes methodology, which we do in the study of operating characteristics in Section 4. The marginal posterior distribution
of δ is found by integrating pi out of (6), giving
p(δ |x0, x?) ∝ B(δx0 + x? + αpi, δ(n0 − x0) + n? − x? + βpi)
B(δx0 + αpi, δ(n0 − x0) + βpi) Be(δ |α, β). (7)
2.3. Empirical Bayes
An alternative to the fully Bayesian methodology is that of empirical Bayes, which estimates hyper-parameters based on
the data. Here we choose the weight parameter with an EB approach, maximising the marginal likelihood of δ,
δˆ(x0, x?) = arg max
δ∈[0,1]
L(δ;x0, x?), (8)
where
L(δ;x0, x?) =
∫
L(θ;x?) p(θ | δ, x0)dθ
=
∫
L(θ;x?) L(θ;x0)
δ p(θ)dθ∫
L(θ;x0)δ p(θ)dθ
. (9)
Note that p(θ | δ, x0) is properly normalised (as in (4)) and that (9) does not have a prior on δ. Using the empirical Bayes
type methodology, we define a new power prior based on the conditional power prior (1) with the estimate (8) of δ
inserted, which we will refer to as the EB power prior. The EB estimate eliminates the need for a prior on δ and, by
using the marginal likelihood based on x0 and x?, it adapts to the current and historical data. We still require a prior on
θ to complete the specification. The EB power prior is still a posterior distribution based on the historical data, but now
conditional on δˆ = δˆ(x0, x?). In the normal case, the EB estimate of δ is available in closed form, see Appendix A.
The EB estimate of δ for the binomial case comes from maximising the likelihood component in (7), which has the
form of a beta-binomial density for x? with parameters δx0 + αpi, δ(n0 − x0) + βpi and n?. There are no closed forms for
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the maximum likelihood estimates of the two parameters of a beta-binomial density, but the functions are well behaved
enough for numerical estimation. It is necessary to limit the search for the maximum to the interval [0,1] for δ.
Note that the EB estimate δˆ is not the same as the “guide value” (δG) given by Ibrahim et al. [20, 19], which comes
from minimizing a penalized likelihood-type criterion,
G(δ) = −2 log (h(δ)) + log(n0)
δ
,
where h(δ) =
∫
L(θ;x?) L(θ;x0)
δ p(θ) dθ (10)
and n0 is the sample size of the historical data. This value is based on the original conditional power prior (1) which
does not include the normalising constant as in (9), and so suffers from the problems discussed by Neuenschwander et al.
[22]. This may be the reason for its counter-intuitive results [20, table 1] where it gives small estimates of δ in the case of
perfect agreement in the normal case. Ibrahim et al. [20] stress that this value should only be used as an initial suggestion
for the choice of δ and that one should conduct any analysis with several values of δ and compare the results. Figure
1(a) compares the guide values with the empirical Bayes estimates. A further examination of the guide value is given in
the normal setting in Appendix A.4. In the binomial setting the guide value does not lead to an estimate of δ = 1, which
may be a desirable property if the sample sizes are small and so there is limited information in the likelihood to estimate
δ. However this property is not generally present in the guide value, as seen in Figure 5 in Appendix A.4, where in the
normal setting the guide value is 1 for a larger range of values than EB.
2.4. Box p-values
Box [2] describes how the prior predictive distribution can be used to test the compatibility of a prior and data. This can
be used to identify unsuitable priors that conflict with the observed data. The test gives a p-value that is the probability of
X? being equal of less likely than the observed x?, in our setting that is
Box p(x? |x0) = Pr{p(X? |x0) ≤ p(X? = x? |x0)}
=
n?∑
x=0
p(x |x0)I{p(x |x0) ≤ p(x? |x0)},
where I{·} is the indicator function. Here p(x? |x0) is the prior predictive distribution of the data x? for the new study,
given the historical data x0. We note that the modified procedure suggested by Evans and Moshonov [12], is equivalent to
that of Box [2] in our case since only summary statistics are used.
The prior predictive distribution for a fixed δ is
p(x? |x0, δ) =
∫ ∞
−∞
p(x? | θ) L(θ;x0, δ) dθ
= BeB(x? |n?, αpi + δx0, βpi + δ(n0 − x0)),
where BeB(x |n, α, β) is the beta-binomial density function. For the fully Bayesian approach, it is
p(x? |x0) ∝
∫ 1
0
BeB(x? |n?, αpi + δx0, βpi + δ(n0 − x0)) p(δ)dδ.
Figure 1(b) shows Box p-value curves for historical data x0/n0 = 65/100 and increasingly differing current data x?/200.
Since the power prior is centred around the historical data, all power priors have large p-values when the current data are
similar to the historical data. However, as the the difference between the current and historical data increases, the Box
p-values rapidly drop. The rate of this decrease depends on size of the historical and current studies. In the special case of
δ = 0, there is no information in the power prior (given a non-informative initial prior), so there can never be prior-data
conflict. The Box p-values for fixed δ > 0 decrease rapidly as x? increases, meaning that the current data conflicts with
the informative power priors.
As the EB prior is controlled by δˆ based on the current and historical data it never conflicts with the new data. Initially
the EB p-values are the same as those from fixed δ = 1 due the upper bound on δ. However, as the difference between
x0/n0 and x?/n? increases, the value of δˆ decreases, as seen in Figure 1(a), which in turn reduces the information in the
prior, thus reducing conflict. As a result of this adjustment the p curve becomes flat. The level of this line is approximately
p = 2(1− Φ(1)) ≈ 0.32, which is the same as in the normal setting, see Figure 5 in Appendix A.4. Held and Sauter
[14] note similar behaviour of Box p-values when using EB estimates for weights in generalised linear models. The
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wiggliness of the lines are due to the discreteness of the beta-binomial distribution. The fully Bayesian approach includes
the additional uncertainty in the weight parameter and thus has a larger variance. This means that, with a uniform prior for
δ, the posterior predictive distribution adapts weakly to the difference in current and historical data, so there is evidence
for prior-data conflict at larger values of x?. The U-shaped Jeffreys’ Be(0.5, 0.5) prior, which as been suggested for the
weight parameter by Dejardin et al. [8], slightly reduces the conflict between the data and the prior by allowing for very
little borrowing when the data and prior are dissimilar, thus decreasing further the probability of conflict. This analysis
shows the limitations of the fixed approach and how easily it leads to prior-data conflict. It also demonstrates that the fully
Bayesian approaches may also exhibit prior-data conflict, depending on the size of the difference and the priors chosen.
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Figure 1. Choices of δ and Box p-values for x? with n? = 200, x0 = 65 and n0 = 100. The behaviours of the curves in both plots are the same as shown for x? decreasing
from 130.
3. Application
To demonstrate the power prior and estimation by EB, we look at an example based on two clinical trials [25, 29]
comparing Linezolid and Vancomycin for the treatment of nosocomial pneumonia. These trials are similar enough that we
might expect that the earlier trial could be informative about the latter. Since we are interested in testing the performance
of the new treatment, we will only take information about the control treatment, Vancomycin. Table 1 shows the results of
the two trials for two outcomes, all cause mortality and cure in the clinically evaluable subset of patients.
Trial All Cause Mortality Clinical Cure
Rubinstein (2001) 49/193 (25.4%) 62/91 (68.1%)
Wunderink (2003) 61/302 (20.2%) 111/171 (64.9%)
Risk Difference 5.2% (p = 0.18) 3.2% (p = 0.68)
95% Confidence Interval -2.4% to 12.8% -8.7% to 15.2%
Table 1. Results of Vancomycin arm in trials
First we look at all cause mortality in the two trials. Taking the results of the Rubinstein et al. trial as the historical data
and the Wunderink et al. trial as the current data, we can estimate the weight parameter and the posterior distributions of
pi and δ, as shown in Figure 2(a) where we have used a uniform prior for δ. The EB estimate is δˆ = 0.44 and based on
(2), we can interpret the posterior as including δˆn0 patients from the historical study in addition to those from the current
study. In this case it is equivalent to 85 additional patients. The conditional posterior of pi | δˆ under EB is not very different
from that of the marginal posterior.
For the cure outcome in the clinically evaluable subset of patients, Figure 2(b) shows the posterior distributions of pi
and δ. The posterior distribution of δ looks rather different to the previous example. The point estimates of the proportions
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Figure 2. Marginal posterior densities of pi and δ based on historical data from Rubinstein et al. [25] and current data from Wunderink et al. [29].
in each trial are closer together and the sample sizes are also smaller, so there is less evidence of a difference between the
trials. This leads to a larger EB estimate, δˆ = 1, meaning 91 extra patients are included in the posterior. This demonstrates
that even when the historical and current data are not identical, it is possible to fully use the historical data with the EB
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EB methodology. The upper and lower dashed diagonal lines represent full and no borrowing respectively. An interim look to calculate δˆ would not be required before the solid
vertical line is reached.
approach. There is now more of a difference between the conditional posterior under EB and the marginal posterior.
3.1. Application to Adaptive Trial
Power priors could be used in an adaptive trial design where the historical information is used to supplement the new
data. An interim analysis would compare the results in the control arm with the historical study and estimate the weight
parameter and thus the number of equivalent patients in the prior. For example, taking the sample sizes from the Wunderink
et al. and Rubinstein et al. trials, consider a new trial with a desired sample size of 302, and a prior based on a historical
trial with 193 patients. If δˆ = 0 and no information is taken from the historical trial, then 302 new patients would need to
be recruited. At the other extreme, if δˆ = 1, then only 302-193=109 new patients would be required. Figure 3 shows how
the expected total number of patients changes as patients are observed in the new trial for different values of pi?, with the
upper and lower bounds shown by dashed lines. The wiggliness is due to the discreteness of the binomial distribution. The
expected total number of patients is calculated as
Expected Total Patients(pi?, n?) = n? + n0
n?∑
x?=0
p(x? |pi?)δˆ(x0, x?).
It would not be necessary to calculate the weight parameter – and potentially modify any study characteristics – until the
minimum possible number of new patients required have been recruited, which in this setting is 109. This allows the value
of δˆ to have stabilised and it can be best seen how many, if any, further patients are required. The EB estimate of the
weight parameter could also be used to guide adaptive randomisation in a manner similar to that described by Schmidli
et al. [26], and Hobbs et al. [16], where the randomisation ratio is adjusted during the trial. A small δ would mean 1:1
randomisation should continue, but a large weight could allow a greater randomisation ratio to concentrate recruitment
into the experimental arm where more evidence is required.
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4. Operating Characteristics
In this section we recreate the analysis of Viele et al. [28] and calculate commonly used operating characteristics for
evaluating hypothesis tests. The scenario is a clinical trial being conducted with a new treatment (T ) and a control treatment
(?) for which a previous clinical trial observed x0/n0 = 65/100 successful outcomes. In the new trial we have 200 patients
in each arm, so we model the outcomes with XT ∼ Bin(200, piT ) and X? ∼ Bin(200, pi?). Initial priors are specified for
the probability parameters in each arm, piT , pi?
iid∼ Be(0.001, 0.001), for consistency with [28].
The hypotheses to test are H0 : piT = pi? versus H1 : piT > pi?. The threshold for evidence in favour of H1 is Pr(piT >
pi? |x?, xT ) > 0.975, which depends on the two posterior distributions, piT ∼ Be(0.001 + xT , 0.001 + 200− xT ) and
pi? ∼ Be(0.001 + 65δ + x?, 0.001 + 35δ + 200− x?).
We compare the mean squared error (MSE), type I error, power, prior sample size, coverage, and bias using power priors
based on the EB estimate of δ, fixed values of δ = 0, 0.2, 0.4, 0.6, 0.8, 1 and two fully Bayesian approaches with different
initial priors for δ, a uniform Be(1, 1) and a U-shaped Be(0.5, 0.5). In addition to the operating characteristics shown in
the next section, we compare the power prior approaches with the test-then-pool approach in the Appendix B.
4.1. Expected Prior Sample Size
The prior sample size can calculated directly from the weight of the historical data. When the initial prior on the parameter
is uninformative, the prior sample size is δ × n0. The expected number of historical observations incorporated in the priors
are shown in Figure 4(a), calculated by taking the expectation over all possible values ofX?. The EB prior borrows strongly
when the new data is similar to the historical data and decreases commensurately as the true value of the parameter moves
away. The fixed approaches have constant sample size. The expected prior sample size of the fully Bayesian approaches are
calculated as the marginal posterior mean of δ, which shows that they tend to include a moderate number of observations,
never including none or all of the historical data. The U-shaped prior shows for a slightly more adaptive behaviour than
the uniform prior.
4.2. Mean Squared Error
The MSE is the expected value of the squared error of a point estimate compared with the true value of pi?, and is calculated
as
MSE(pi? | δ) =
n?∑
x?=0
(pi? − pˆi?)2 Pr(x? |pi?),
where Pr(x? |pi?) is the binomial probability mass function. Following Viele et al. [28], we use the posterior mean as
this point estimate. For the EB and conditional power priors, we use the posterior mean of the conditional posterior,
p(pi? |x0, x?, δ), which has a beta distribution, so the mean is pˆi = (65δ + x? + 0.001)/(100δ + 200 + 0.002). For the FB
power prior, we find the mean by numerically integrating over the the marginal posterior, p(pi? |x0, x?).
Figure 4(b) shows that all methods that incorporate historical information have the least error when the current study
has the same success proportion as the historical data. The MSE of the methods with fixed weighting increase as the true
proportion of the new study moves away from the historical proportion. For the adaptive Bayesian methods, the MSE also
increases for small differences between historical and true proportion, but as the difference between the historical data and
true parameter becomes large their adaptive nature becomes apparent and the MSE begins to decrease.
The δ = 0 curve is relatively flat but shows clearly the decrease in MSE due to the decreasing variance of the binomial
distribution with larger probabilities which affects all methods. The δ = 1 curve shows the clear effect on the MSE of
the bias increase from inappropriately using historical data at the extremes and of the decreased variance from larger
sample size in the centre. The other fixed values behave between these two extreme behaviours. The adaptive methods
have similar curves: showing small error near the historical data, increasing as the true parameter differs, before reducing
again as the adaptive borrowing reduces the influence of the historical data. Since the EB method adapts most flexibly and
borrows the most around the historical data, its MSE increases initially quite sharply. However as the historical data and
truth diverge, it corrects sooner than the other methods and decreases again. The full Bayes approach with the uniform
prior has larger MSE for pi? ≈ 0.65 due to borrowing less and increases only slowly for the same reason. It is also slower
to adapt to differences between historical and current data leading to larger MSE when the true proportion is far from
the historical data. For full Bayes with the U-shaped Be(0.5, 0.5) prior, we again see that it shows more adaptiveness. It
borrows more strongly when there is good compatibility between current and historical data, and reduces borrowing for
smaller differences between current and historical data than with the flat prior. However, before the reduction occurs, it
borrows very strongly, and so has the largest values for MSE among the adaptive methods considered.
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4.3. Type I Error
To examine the type I error of the hypothesis test described earlier, the probability of success in each trial arm is assumed
to be equal, pi = pi? = piT . The probability of a falsely declaring a difference is
Type I Error(pi?) =
∑
x?
∑
xT
Pr(x? |pi = pi?)Pr(xT |pi = pi?)I{Pr(pi? < piT |x?, xT ) > 0.975}
where
Pr(pi? < piT |x?, xT ) =
∫ 1
0
∫ 1
pi?
pT (piT |xT ) p(pi? |x?)dpiT dpi?. (11)
Due to the nature of a one-sided test, all methods that incorporate historical information have lower than nominal type
I error when the true value is smaller than the historical data and inflated error when the historical data is larger. We
are primarily concerned with type I error inflation, which could lead to incorrect conclusions from a clinical trial. The
type I errors are shown in Figure 4(c). The adaptive methods have increased error where they borrow, and following the
same pattern seen previously, EB has larger error due to its strong borrowing before reducing sharply as it corrects for the
difference in historical and current data. The full Bayes approaches are very similar here, with a smaller increase in type
I error than EB, but weaker correction as the difference grows large. The Be(0.5, 0.5) prior again adapts more than the
Be(1, 1), but this only makes an impact when the true parameter far from the historical data.
4.4. Power
Correspondingly, we can calculate the power to detect a difference of 0.12 between the control and experimental treatment
with
Power(pi?) =
∑
x?
∑
xT
Pr(x? |pi?)Pr(xT |pi? + 0.12)I{Pr(pi? < piT |x?, xT ) > 0.975},
where Pr(pi? < piT |x?, xT ) is the same as in (11). The power curves are shown in Figure 4(d). Since we are looking at a
one-sided test, the methods can lose power if too much historical information greater than the true parameter is borrowed,
but gain power by borrowing when the historical data is less than the true parameter. The δ = 0 curve shows there is a
natural increase in power as the true value of pi? increases, due to the decrease in variance of the binomial distribution for
more extreme proportions.
In the left third of the plot the intermediate fixed approaches have less power compared to δ = 0 as they are influenced
by the historical data which has a larger proportion than the true value, so the difference of 0.12 is harder to detect. The
EB approach does not suffer reduced power because the historical data is only used to a small extent. The FB approaches
are again similar and have a large decrease in power compared to EB due to their moderate borrowing. In the centre of
the plot, where the true parameter and historical data align, all methods that incorporate historical data are more powerful
than δ = 0 due to the increased data. EB is most powerful among the adaptive methods because it borrows most strongly.
In the right third of the plot, we again see the effect of the bias induced by borrowing: the power increases as the estimate
of pi? is shrunken towards 0.65, therefore making the difference easier to detect. The power of the EB approach flattens as
it reduces borrowing. The FB approaches continue increasing in power but tend toward the power level of the δ = 0 curve.
4.5. Coverage
To assess the impact of the priors on the whole distribution of pi?, rather than just the mean, we look at the coverage
probabilities. The coverage of 95% equi-tailed credible intervals of the posterior distributions for pi? are shown in Figure
4(e). Specifically, the coverage is computed as
Coverage(pi?) =
∑
x?
Pr(x? |pi?)I{l(0.025, x?) < pi? < u(0.025, x?)},
where the upper and lower limits come from the quantile functions, l(p, x?) = {l :
∫ l
−∞ p(θ? |x?, x0) = p} and u(p, x?) =
{u |u ∈ (0, 1) : ∫∞
u
p(pi? |x?, x0) = p}. For the fixed and EB methods, pi? has a beta distribution with parameters
δx0 + x? + αpi and δ(n0 − x0) + n? − x? + βpi, so the quantile functions are available. The full Bayes calculations require
numerical integration over (6).
Since the coverage of binomial estimators are unstable, we apply a smoothing procedure [1]. This smoother estimates
the local coverage at each point based on beta kernels and we use a smoothing parameter based on the standard deviation
of the binomial estimator, SD(pˆi? = x?/n?) =
√
pi?(1− pi?)/n? ≈ 0.03, assuming pi? is near to the historical data.
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Figure 4. Operating characteristics of fixed, EB and FB methods for historical data x0/n0 = 0.65 and varying true parameter pi?.
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All methods which include the historical data bias the posterior distribution towards the historical data. This means
that we observe have higher than nominal coverage when the true parameter is near the historical data, which is expected
because the credible interval is shifted towards x0/n0 and so may include the true parameter, even if the observed value
of x?/n? is far from pi? and x0/n0. Conversely, when the true pi? is away from the historical data, we see a reduction in
the coverage level due to the bias towards the historical data. By using adaptive methods, we expect that there will be less
reduction in coverage due to the dynamic reduction in borrowing and therefore bias. The EB and FB priors have similar
behaviour, showing a large drop in coverage as the difference between the true pi? and x0/n0 increases, before increasing
back towards the nominal level for larger differences. The EB prior drops sharply to less than 90% before increasing back
towards the nominal level. The FB approaches decrease less sharply, with their minimum coverage always larger than
90%. They increase again, more slowly than EB, with the Be(0.5, 0.5) prior increasing slightly faster.
4.6. Bias
Complementary to the examination of the MSE, it is useful to look at the bias in the parameter estimates. Here bias is
calculated as the expected difference of the posterior mean from the true value, EX? |pi?(pi? − p˜i?). As for the MSE, the
mean comes from the conditional posterior for EB and conditional power priors and from the marginal posterior for FB.
Figure 4(e) shows that there is negligible difference between the level of bias between the adaptive methods when the
true parameter is near the historical data. However as the difference grows the EB method’s more sensitive adaptiveness
reduces the weight of the historical data to reduce the bias.
5. Discussion
The power prior is a flexible method for specifying an informative prior: it calculates a posterior distribution from a prior
and the weighted likelihood of some previous data. This posterior is then used as the prior for a new study. The major
criticism of the power prior has been the difficulty in choosing the weight parameter. We have proposed an empirical
Bayes approach that estimates the weight parameter based on the maximum of the marginal likelihood given the new and
old data. We compared this to the fully Bayesian approach of integrating out the weight parameter, as well as to fixed
weights.
The EB approach takes care that the power prior is always compatible with the current data, as seen by the Box p-values
never becoming small. It works because the EB estimate reduces the level of information in the prior when necessary. The
fully Bayesian approach is adaptive by nature, but does not react as strongly to the differences between the current and
historical data. Therefore we see that with fixed weight δ > 0 or the fully Bayesian approach, the power prior methodology
can lead to priors that conflict with the current data.
A considerable benefit of the EB estimation is that it can give a weight of 1 to the historical study, which is not the
case for the fully Bayesian approach, which, even for identical historical and current data, has posterior mean δ ≈ 0.6 for
δ ∼ Be(1, 1) a priori. The fully Bayesian approach can be induced to give larger weights by using strong priors on δ, but
this would require specific justification. A general criticism of EB is that it does not account for any uncertainty in the
parameters it estimates, in this case the weight parameter δ. The greatest impact of this is when the data are similar and EB
estimates a large weight, leading to a narrower posterior than with the fully Bayesian approach. This trade off is necessary
for the good adaptive performance, and the methodology still accounts for the uncertainty in the parameter of interest θ?.
A necessary condition for the implementation of the adaptive trial described in Section 3.1 is the comparison of the
outcomes of the current patients with those of the historical patients. This requires that the current control arm data be
unblinded to whomever is responsible for determining the weight parameter. Many adaptive designs also require such
unblinding, so whether this is problematic depends on the context surrounding the design of the trial. The EB power prior
methodology provides a reasonable approach to incorporating down-weighted historical data into clinical trials, and if
unblinding is not possible the FB approach could be applied.
In case there is more than one relevant historical study available, then it may be appropriate to include them separately
in the power prior and have different weights for each. The literature on choosing multiple power prior parameters is
fairly sparse; with many papers making a brief remark as to its possibility and difficulty. Notably, Duan [9, ch. 4] presents
an example using a fully Bayesian approach. We have chosen not to include another such section and look to prepare
a more complete treatment in a future paper. Power priors with individually weighted studies present challenges both
mathematically and computationally. The EB approach is, however, feasible. We believe that power priors are still an
attractive method despite the challenges, as the weight parameter is very interpretable for compatibility of studies and
sample size when compared to the between study heterogeneity parameter in a hierarchical model.
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A. Normal Power Prior
As with the binomial setting, it is possible to construct a power prior with a normal likelihood. In the normal setting with
an unknown µ, we assume both the historical and current data are realisations of normal random variables and that the
parameter of interest is the mean of the current data, so the likelihoods used, L(µ;x0) and L(µ;x?), are based on normal
densities. We set the variances of these distributions, σ20 and σ2?, to the squared standard error of the parameters of interest
µ, and so they are treated as fixed in the following derivation. In contrast to the binomial case, many quantities are now
available in closed form.
A.1. Power Prior
In the normal setting with unknown mean µ and fixed variance σ20 , the power prior is
p(µ |x0, δ) ∝ (2piσ20)−δ/2 exp
(
−δ(µ− x0)
2
2σ20
)
p(µ).
The posterior, based on x? and σ2?, is
p(µ |x?, x0, δ) ∝ (2pi)−(1+δ)/2σ−δ0 σ−1? exp
(
− (µ− x?)
2
2σ2?
− δ(µ− x0)
2
2σ20
)
p(µ),
so with a flat initial prior for µ we have
µ |x?, x0, δ ∼ N
((
x?
σ2?
+
δx0
σ20
)(
1
σ2?
+
δ
σ20
)−1
,
(
1
σ2?
+
δ
σ20
)−1)
.
A.2. Full Bayes
The joint power prior based on (3) for µ and δ, assuming a uniform prior on µ and fixed variance, is [21]
p(µ, δ |x0) = N(x0 |µ, σ20/δ) Be(δ |α, β).
Duan et al. [11] also derive a more general form allowing for unknown variance, which requires bounds on the range of δ
depending on the prior on σ20 . The joint posterior distribution is proportional to the joint prior multiplied by the likelihood
of the current data, L(µ;x?),
p(µ, δ |x?, x0) ∝ N(x? |µ, σ2?) N(x0 |µ, σ20/δ) Be(δ |α, β). (12)
To obtain the marginal posterior distribution of µ, which is the basis for a fully Bayesian approach, we integrate δ out of
(12), so
p(µ |x?, x0) ∝
∫ 1
0
p(µ, δ |x?, x0) dδ
∝
∫ 1
0
N(x? |µ, σ2?) N(x0 |µ, σ20/δ) Be(δ |α, β) dδ
= N(x? |µ, σ2?)
1
B(α, β)
1√
2piσ20
∫ 1
0
√
δ Exp
(
δ
(x0 − µ)2
−2σ20
)
δα−1(1− δ)β−1 dδ
= N(x? |µ, σ2?)
1
B(α, β)
1√
2piσ20
Γ(α+ 1/2)Γ(β) M
(
1
2
+ α,
1
2
+ α+ β,− (x0 − µ)
2
2σ20
)
∝ exp
(
− (x? − µ)
2
2σ2?
)
M
(
1
2
+ α,
1
2
+ α+ β,− (x0 − µ)
2
2σ20
)
,
where M(a, b, z) = 1/(Γ(a)Γ(b− a)) ∫ 1
0
eztta−1(1− t)b−a−1 dt is the confluent hypergeometric function [23, Sec 13.4]
which is implemented in standard numerical mathematics libraries. No further estimation of parameters is required and
we can use this distribution for inference on µ. Similarly, the marginal posterior of δ is found by integrating µ out of (12),
giving
p(δ |x?, x0) ∝
{
N(x? |x0, σ20/δ + σ2?) Be(δ |α, β) if 0 < δ < 1
0 otherwise.
(13)
This marginal distribution can be used to examine the behaviour of the weight parameter for different values of x0 and x?.
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A.3. Empirical Bayes
To find (9) in the normal setting, we integrate µ out of the joint likelihood (i. e. (12) without the Be(δ |α, β) prior term) to
give the marginal likelihood with respect to δ,
L(δ;x?, x0) ∝ N(x? |x0, σ20/δ + σ2?). (14)
Since this has the form of a normal likelihood, we can use the invariance property of the maximal likelihood estimate
(x? − x0)2 of the variance and solve for δ. The value of δ which maximises (14) is
δˆ =
σ20
max{(x? − x0)2, σ2? + σ20} − σ2?
, (15)
where the max is required to restrict δˆ ≤ 1. Substituting this estimate into the conditional posterior distribution of µ gives
the EB posterior distribution,
p(µ |x?, x0, δ = δˆ) ∝
{
N(µ |x?, σ2?)×N(µ |x0, (x? − x0)2 − σ2?) if (x0 − x?)2 > σ2? + σ20
N(µ |x?, σ2?)×N(µ |x0, σ20) otherwise.
The availability of analytical forms for δˆ and the marginal distributions makes working with EB very fast and easy in the
normal setting.
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Figure 5. Choices of δ and Box p-values for x? with x0 = 10 and σ20 = σ
2
? = 1/n0 = 1/100. The guide value line in (b) traces exactly the δ = 1 line.
A.4. Guide value
We now examine the guide value in the normal setting and compare the suggested δG values with the EB estimate δˆ.
Firstly, inserting normal likelihoods into (10) gives
h(δ) = exp
(
− (x0 − x?)
2
2(σ20/δ + σ
2
?)
)(
(2piσ20)
δσ2?
(
δ
σ20
+
1
σ2?
))−1/2
,
which is used in G(δ), which we search numerically for δG = arg min G(δ). Note that due to the use of the unnormalised
conditional power prior, h(δ) includes an extra term involving δ, (2piσ20)−δ/2, as compared to the marginal likelihood (14).
Statist. Med. 0000, 00 1–17 Copyright © 0000 John Wiley & Sons, Ltd. www.sim.org 15
Prepared using simauth.cls
I Gravestock, L Held
Ibrahim et al. [20] give an example in a normal setting with varying x?, fixed x0 = 10, and variances σ20 = σ2? = 1/n0 =
1/n? = 1/100, which we replicate here. Figure 5(a) shows the different behaviours of the guide value δG and EB δˆ. The
greatly increased range of x? values for which δG = 1 as compared to EB is due to the penalty term, log(n0)/δ, which
penalises smaller values of δ, and therefore increases the minimising value, δG. The blue dots show the values of δG given
in [20], which we were not able to reproduce, although our results do become close for very large differences between x0
and x?. For example when x? = 50, both our calculated δG and δG given in [20] are 0.005.
The values given by Ibrahim et al. [20, table 1 and 2] are shown in Tables 2 and 3. The left side of each table varies the
current study size with 100 patients in the historical study and the right side varies the historical size with 100 in the new
study.
n δ | s20 = 1 δ | s20 = 0.5 n0 δ | s20 = 1 δ | s20 = 0.5
5 0.126 0.139 5 0.349 0.378
10 0.127 0.139 10 0.289 0.317
50 0.127 0.140 50 0.166 0.183
100 0.127 0.140 100 0.127 0.140
200 0.128 0.140 200 0.097 0.106
1000 0.128 0.140 1000 0.049 0.054
100000 0.128 0.141 100000 0.006 0.007
Table 2. Guide values for identical historical data and current data, i. e. x? = x0 = 10, current variance σ2? = 1 and
differing historical variance
n δ |x0 = 15 δ |x0 = 50 n0 δ |x0 = 15 δ |x0 = 50
5 0.085 0.006 5 0.108 0.014
10 0.060 0.006 10 0.092 0.012
50 0.044 0.005 50 0.054 0.007
100 0.042 0.005 100 0.042 0.005
200 0.041 0.005 200 0.033 0.004
1000 0.041 0.005 1000 0.018 0.002
100000 0.041 0.005 100000 0.006 0.000
Table 3. Guide values for differing historical data and fixed current data and variances, x? = 10, σ2? = σ20 = 1
For all entries in Table 2, the EB values from equation (15) are δˆ = 1, since the data are identical. For Table 3, δˆ = 0.04
when x0 = 15 and δˆ = 6× 10−4 when x0 = 50. Under EB the estimates do not depend directly on the size of either
the current or historical study, rather only through the variance of the x0 and x?. Figure 6 shows the historical data and
conditional posteriors using EB and guide values.
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Figure 6. Conditional posterior distribution of µ given δ for x0 = 10 and x? = 10 or 50 with variances σ20 = σ
2
? = 1 and sample sizes n = n0 = 100.
B. Test-then-Pool Operating Characteristics
A non-Bayesian alternative that allows pooling dependent on the historical and current data is the test-then-pool
methodology [28]. First, the difference between current and historical data is tested at some predefined significance level
α, then if the difference is not significant, the data are pooled and if the difference is significant, the historical data is
ignored. The significance level used in this testing step need not be the same as that used in the final testing of control
versus treatment. When a two-sided Fisher test is used with α = 0.2, the all cause mortality data with p = 0.18 would
ignore x0, whereas the clinical cure data which has p = 0.68 would pool x0 and x?. Such an all-or-nothing approach with
a strict but arbitrary cut-off does not seem appropriate and small differences in observed data could lead to very different
results. We consider significance levels of α = 1, 0.2, 0.1, 0.05, 0.01, 0 for the initial test. The operating characteristics of
these test-then-pool and power priors share a similar shape in many cases. The results are shown in Figure 7.
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Figure 7. Operating characteristics comparing test then pool method with power priors for historical data pˆi = 0.65 and varying true parameter pi?.
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